Aurinia Pharmaceuticals Inc.AUPHNASDAQ
LOADING
|||
Cash Generation Expanding
Trending higher, above historical average.
Left:
||||
Operating cash flow minus capital expenditures
Latest
$44.11M
↑ 188% above average
Average (9y)
$-49.94M
Historical baseline
Range
High:$44.11M
Low:$-159.19M
CAGR
NaN%
Modest growth trend
| Period | Value | Change |
|---|---|---|
| 2024 | $44.11M | +229.0% |
| 2023 | $-34.18M | +57.2% |
| 2022 | $-79.82M | +49.9% |
| 2021 | $-159.19M | -106.2% |
| 2020 | $-77.20M | -21.2% |
| 2019 | $-63.69M | -23.2% |
| 2018 | $-51.69M | -25.5% |
| 2017 | $-41.19M | -119.8% |
| 2016 | $-18.74M | -5.2% |
| 2015 | $-17.82M | - |